Logo image of GIN.DE

GIVAUDAN-REG (GIN.DE) Stock Fundamental Analysis

Europe - FRA:GIN - CH0010645932 - Common Stock

3663 EUR
-139 (-3.66%)
Last: 10/29/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to GIN. GIN was compared to 66 industry peers in the Chemicals industry. GIN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, GIN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year GIN was profitable.
In the past year GIN had a positive cash flow from operations.
Each year in the past 5 years GIN has been profitable.
Each year in the past 5 years GIN had a positive operating cash flow.
GIN.DE Yearly Net Income VS EBIT VS OCF VS FCFGIN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

GIN's Return On Assets of 9.01% is amongst the best of the industry. GIN outperforms 89.86% of its industry peers.
With an excellent Return On Equity value of 23.81%, GIN belongs to the best of the industry, outperforming 97.10% of the companies in the same industry.
GIN's Return On Invested Capital of 13.14% is amongst the best of the industry. GIN outperforms 92.75% of its industry peers.
GIN had an Average Return On Invested Capital over the past 3 years of 11.29%. This is above the industry average of 7.12%.
The last Return On Invested Capital (13.14%) for GIN is above the 3 year average (11.29%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.01%
ROE 23.81%
ROIC 13.14%
ROA(3y)8.16%
ROA(5y)7.72%
ROE(3y)22.13%
ROE(5y)21.72%
ROIC(3y)11.29%
ROIC(5y)10.9%
GIN.DE Yearly ROA, ROE, ROICGIN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of GIN (14.71%) is better than 94.20% of its industry peers.
GIN's Profit Margin has improved in the last couple of years.
GIN has a Operating Margin of 18.96%. This is amongst the best in the industry. GIN outperforms 91.30% of its industry peers.
In the last couple of years the Operating Margin of GIN has grown nicely.
The Gross Margin of GIN (44.13%) is better than 60.87% of its industry peers.
GIN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.96%
PM (TTM) 14.71%
GM 44.13%
OM growth 3Y4.7%
OM growth 5Y4.36%
PM growth 3Y6.18%
PM growth 5Y5.38%
GM growth 3Y1.09%
GM growth 5Y1.59%
GIN.DE Yearly Profit, Operating, Gross MarginsGIN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so GIN is creating value.
The number of shares outstanding for GIN remains at a similar level compared to 1 year ago.
Compared to 5 years ago, GIN has more shares outstanding
Compared to 1 year ago, GIN has an improved debt to assets ratio.
GIN.DE Yearly Shares OutstandingGIN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
GIN.DE Yearly Total Debt VS Total AssetsGIN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

GIN has an Altman-Z score of 4.44. This indicates that GIN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of GIN (4.44) is better than 86.96% of its industry peers.
The Debt to FCF ratio of GIN is 3.57, which is a good value as it means it would take GIN, 3.57 years of fcf income to pay off all of its debts.
GIN's Debt to FCF ratio of 3.57 is amongst the best of the industry. GIN outperforms 85.51% of its industry peers.
A Debt/Equity ratio of 0.86 indicates that GIN is somewhat dependend on debt financing.
The Debt to Equity ratio of GIN (0.86) is worse than 73.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 3.57
Altman-Z 4.44
ROIC/WACC2.89
WACC4.55%
GIN.DE Yearly LT Debt VS Equity VS FCFGIN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

GIN has a Current Ratio of 1.49. This is a normal value and indicates that GIN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of GIN (1.49) is comparable to the rest of the industry.
A Quick Ratio of 0.98 indicates that GIN may have some problems paying its short term obligations.
GIN has a Quick ratio (0.98) which is in line with its industry peers.
The current and quick ratio evaluation for GIN is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 0.98
GIN.DE Yearly Current Assets VS Current LiabilitesGIN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.21% over the past year.
Measured over the past 5 years, GIN shows a small growth in Earnings Per Share. The EPS has been growing by 6.04% on average per year.
GIN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.93%.
GIN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.63% yearly.
EPS 1Y (TTM)4.21%
EPS 3Y11.12%
EPS 5Y6.04%
EPS Q2Q%0.69%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y3.51%
Revenue growth 5Y3.63%
Sales Q2Q%3.4%

3.2 Future

Based on estimates for the next years, GIN will show a small growth in Earnings Per Share. The EPS will grow by 5.29% on average per year.
Based on estimates for the next years, GIN will show a small growth in Revenue. The Revenue will grow by 4.53% on average per year.
EPS Next Y3.67%
EPS Next 2Y4.22%
EPS Next 3Y5.1%
EPS Next 5Y5.29%
Revenue Next Year1.56%
Revenue Next 2Y2.39%
Revenue Next 3Y3.29%
Revenue Next 5Y4.53%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GIN.DE Yearly Revenue VS EstimatesGIN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
GIN.DE Yearly EPS VS EstimatesGIN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50 100 150

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 27.23, which means the current valuation is very expensive for GIN.
The rest of the industry has a similar Price/Earnings ratio as GIN.
The average S&P500 Price/Earnings ratio is at 26.11. GIN is around the same levels.
With a Price/Forward Earnings ratio of 25.16, GIN can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, GIN is valued a bit more expensive than 65.22% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.55. GIN is around the same levels.
Industry RankSector Rank
PE 27.23
Fwd PE 25.16
GIN.DE Price Earnings VS Forward Price EarningsGIN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

71.01% of the companies in the same industry are cheaper than GIN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GIN indicates a somewhat cheap valuation: GIN is cheaper than 68.12% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 23.57
EV/EBITDA 19.8
GIN.DE Per share dataGIN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of GIN may justify a higher PE ratio.
PEG (NY)7.41
PEG (5Y)4.51
EPS Next 2Y4.22%
EPS Next 3Y5.1%

5

5. Dividend

5.1 Amount

GIN has a Yearly Dividend Yield of 2.11%.
GIN's Dividend Yield is a higher than the industry average which is at 3.21.
Compared to an average S&P500 Dividend Yield of 2.37, GIN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.11%

5.2 History

The dividend of GIN has a limited annual growth rate of 2.07%.
Dividend Growth(5Y)2.07%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

57.52% of the earnings are spent on dividend by GIN. This is a bit on the high side, but may be sustainable.
The dividend of GIN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP57.52%
EPS Next 2Y4.22%
EPS Next 3Y5.1%
GIN.DE Yearly Income VS Free CF VS DividendGIN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
GIN.DE Dividend Payout.GIN.DE Dividend Payout, showing the Payout Ratio.GIN.DE Dividend Payout.PayoutRetained Earnings

GIVAUDAN-REG

FRA:GIN (10/29/2025, 7:00:00 PM)

3663

-139 (-3.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-14 2025-10-14
Earnings (Next)01-29 2026-01-29/amc
Inst Owners34.16%
Inst Owner ChangeN/A
Ins Owners12.15%
Ins Owner ChangeN/A
Market Cap33.81B
Revenue(TTM)7.54B
Net Income(TTM)1.09B
Analysts72.41
Price Target4368.31 (19.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.11%
Yearly Dividend73.17
Dividend Growth(5Y)2.07%
DP57.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.82%
PT rev (3m)-2.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.72%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.46%
Valuation
Industry RankSector Rank
PE 27.23
Fwd PE 25.16
P/S 4.24
P/FCF 23.57
P/OCF 19.32
P/B 6.86
P/tB N/A
EV/EBITDA 19.8
EPS(TTM)134.53
EY3.67%
EPS(NY)145.59
Fwd EY3.97%
FCF(TTM)155.39
FCFY4.24%
OCF(TTM)189.57
OCFY5.18%
SpS864.69
BVpS534.07
TBVpS-29.17
PEG (NY)7.41
PEG (5Y)4.51
Graham Number1271.45
Profitability
Industry RankSector Rank
ROA 9.01%
ROE 23.81%
ROCE 15.16%
ROIC 13.14%
ROICexc 14.32%
ROICexgc 33.12%
OM 18.96%
PM (TTM) 14.71%
GM 44.13%
FCFM 17.97%
ROA(3y)8.16%
ROA(5y)7.72%
ROE(3y)22.13%
ROE(5y)21.72%
ROIC(3y)11.29%
ROIC(5y)10.9%
ROICexc(3y)12.12%
ROICexc(5y)11.56%
ROICexgc(3y)26.36%
ROICexgc(5y)25.23%
ROCE(3y)13.03%
ROCE(5y)12.58%
ROICexgc growth 3Y11.26%
ROICexgc growth 5Y9.01%
ROICexc growth 3Y9.76%
ROICexc growth 5Y7.13%
OM growth 3Y4.7%
OM growth 5Y4.36%
PM growth 3Y6.18%
PM growth 5Y5.38%
GM growth 3Y1.09%
GM growth 5Y1.59%
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 3.57
Debt/EBITDA 2.23
Cap/Depr 81.62%
Cap/Sales 3.95%
Interest Coverage 15.27
Cash Conversion 92.12%
Profit Quality 122.2%
Current Ratio 1.49
Quick Ratio 0.98
Altman-Z 4.44
F-Score7
WACC4.55%
ROIC/WACC2.89
Cap/Depr(3y)97.93%
Cap/Depr(5y)83.59%
Cap/Sales(3y)4.95%
Cap/Sales(5y)4.45%
Profit Quality(3y)99.97%
Profit Quality(5y)111.02%
High Growth Momentum
Growth
EPS 1Y (TTM)4.21%
EPS 3Y11.12%
EPS 5Y6.04%
EPS Q2Q%0.69%
EPS Next Y3.67%
EPS Next 2Y4.22%
EPS Next 3Y5.1%
EPS Next 5Y5.29%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y3.51%
Revenue growth 5Y3.63%
Sales Q2Q%3.4%
Revenue Next Year1.56%
Revenue Next 2Y2.39%
Revenue Next 3Y3.29%
Revenue Next 5Y4.53%
EBIT growth 1Y25.45%
EBIT growth 3Y8.37%
EBIT growth 5Y8.14%
EBIT Next Year28.87%
EBIT Next 3Y12.05%
EBIT Next 5Y10.03%
FCF growth 1Y45.57%
FCF growth 3Y8.88%
FCF growth 5Y10.3%
OCF growth 1Y18.35%
OCF growth 3Y8.06%
OCF growth 5Y7.42%

GIVAUDAN-REG / GIN.DE FAQ

Can you provide the ChartMill fundamental rating for GIVAUDAN-REG?

ChartMill assigns a fundamental rating of 6 / 10 to GIN.DE.


What is the valuation status for GIN stock?

ChartMill assigns a valuation rating of 3 / 10 to GIVAUDAN-REG (GIN.DE). This can be considered as Overvalued.


Can you provide the profitability details for GIVAUDAN-REG?

GIVAUDAN-REG (GIN.DE) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for GIN stock?

The Price/Earnings (PE) ratio for GIVAUDAN-REG (GIN.DE) is 27.23 and the Price/Book (PB) ratio is 6.86.


What is the expected EPS growth for GIVAUDAN-REG (GIN.DE) stock?

The Earnings per Share (EPS) of GIVAUDAN-REG (GIN.DE) is expected to grow by 3.67% in the next year.